Zobrazeno 1 - 10
of 115
pro vyhledávání: '"N. A. TOMILINA"'
Publikováno v:
Vestnik Transplantologii i Iskusstvennyh Organov, Vol 21, Iss 3, Pp 39-52 (2019)
Aim: to evaluate the efficacy and safety of early use of everolimus in combination with a reduced dose of calcineurin inhibitors (CNI) after kidney transplantation and define approaches to the selection and management of patients on everolimus-based
Externí odkaz:
https://doaj.org/article/f777a9dc22e045f3a60fd38b13b5068e
Autor:
E. S. Stolyarevich, N. A. Tomilina
Publikováno v:
Трансплантология (Москва), Vol 0, Iss 1, Pp 19-31 (2018)
Grafted kidney abnormalities include a wide spectrum of diseases that differ in their nature, mechanisms of development, and rates of progression. In the early period after renal transplantation, the most important cause of graft dysfunction remains
Externí odkaz:
https://doaj.org/article/84a5d2dd582747a3b53e169fa0538c9f
Autor:
N. A. Tomilina
Publikováno v:
Трансплантология (Москва), Vol 0, Iss 4, Pp 56-59 (2018)
The issues of the circulation of original brand-name immunosuppressants with a narrow therapeutic window and their generics.
Externí odkaz:
https://doaj.org/article/7371f1fbc74345a5ae0ee19dc9ee23ab
Autor:
E. S. Stolyarevich, T. R. Zhilinskaya, L. Yu. Artyukhina, I. G. Kim, V. A. Zaydenov, N. A. Tomilina
Publikováno v:
Vestnik Transplantologii i Iskusstvennyh Organov, Vol 20, Iss 1, Pp 45-54 (2018)
Aim: to analyze the frequency of different histological diagnoses and it simpact on graft survival in a cohort of patients with renal allograft dysfunction, and to determine pathology features, infl uencing prognosis.Materials and methods. The data o
Externí odkaz:
https://doaj.org/article/97cb3e5e77aa4bcbaec98ba30d58c186
Publikováno v:
Vestnik Transplantologii i Iskusstvennyh Organov, Vol 19, Iss 4, Pp 16-26 (2018)
Malignancy is one of the leading causes of death in recipients with a kidney grafts. The use of proliferative signal inhibitors (PSI) is one of the approaches to solve this problem.Aim: to evaluate the effi cacy and safety of everolimus in combinati
Externí odkaz:
https://doaj.org/article/e4db57360d3a455391b4255b962f26d0
Autor:
E. M. Zeltyn-Abramov, R. T. Iskhakov, L. Yu. Artyukhina, E. S. Ivanova, O. V. Manchenko, N. I. Belavina, N. A. Tomilina
Publikováno v:
Vestnik Transplantologii i Iskusstvennyh Organov, Vol 19, Iss 1, Pp 57-62 (2017)
Case report of reversible high pulmonary hypertension (PH) in patient with successful kidney transplantation (KT) is presented. The distinction of the case was the functioning arteriovenous fistula (AVF) with excessive blood flow during 15 years in t
Externí odkaz:
https://doaj.org/article/d6089c85704f46d1b4a02f2435ad1920
Autor:
E. S. Ivanova, E. S. Stolyarevich, O. E. Gichkun, N. B. Bogdanova, F. S. Baranova, L. Yu. Artyukhina, N. A. Tomilina
Publikováno v:
Vestnik Transplantologii i Iskusstvennyh Organov, Vol 18, Iss 3, Pp 39-49 (2016)
Aim: to analyze the relationship between circulating anti-HLA antibodies (class-I and class-II), renal pathology and C4d deposition in cases of late acute and chronic antibody-mediated renal allograft rejection according to the method of antibodies d
Externí odkaz:
https://doaj.org/article/ed7b205a232847119df60c5e8cb2383d
Publikováno v:
Трансплантология (Москва), Vol 0, Iss 3, Pp 6-16 (2016)
Externí odkaz:
https://doaj.org/article/229c0559b7794e9d8f46a4d68651c96f
Autor:
E. S. Stolyarevich, S. V. Badaeva, N. A. Tomilina, I. G. Kim, L. Y. Artyukhina, N. D. Fedorova, I. A. Bukharina
Publikováno v:
Vestnik Transplantologii i Iskusstvennyh Organov, Vol 17, Iss 1, Pp 59-67 (2015)
The aim of the study was the evaluation of pharmacokinetic parameters and clinical efficacy of generic cyclosporine (Ecoral) and Sandimmune Neoral. Materials and methods’. The pharmacokinetic parameters of different cyclosporine formulations. In 19
Externí odkaz:
https://doaj.org/article/6781eee74e12480080caf0af616517d9
Autor:
N. A. Tomilina, B. T. Bikbov
Publikováno v:
Vestnik Transplantologii i Iskusstvennyh Organov, Vol 17, Iss 1, Pp 35-58 (2015)
The report of the Russian Renal Replacement Therapy Registry covers the period from the year 1998 to 2011 and represents data on the national, regional, and individual patient levels. We summarize information about epidemiology of treated end-stage r
Externí odkaz:
https://doaj.org/article/9e89ebc9cff647c69bfaa2018fc48d84